Raúl Migliarini
About Raúl Migliarini
Raúl Migliarini is the Business Unit Manager Oncology at Bristol-Myers Squibb in New York, with extensive experience in marketing and management roles across various companies.
Current Title and Role
Raúl Migliarini currently holds the position of Business Unit Manager Oncology at Bristol-Myers Squibb, based in New York, New York, United States. In this role, Raúl oversees the oncology business unit, ensuring the strategic and effective management of oncology-related products and initiatives. His leadership has been pivotal in steering the unit towards achieving its goals and objectives.
Experience at Bristol-Myers Squibb
Raúl Migliarini has a long history with Bristol-Myers Squibb, having served in various roles over two separate periods. Initially, he was Marketing Director in Venezuela from 1993 to 2005, a role he held for 12 years. Later, he took on the position of Director de Marketing from 2003 to 2005. Since 2011, he has been leading the oncology business unit at the company, demonstrating his commitment and expertise in the pharmaceutical industry.
Previous Roles at Abbott
Raúl's career at Abbott includes two key positions. He started as a Product Manager from 1985 to 1991, a period of six years. Raúl later returned to Abbott in Venezuela as the Business Unit Manager for EPD in 2011, serving in this role for five months. These experiences have contributed significantly to his prowess in managing business units in the pharmaceutical sector.
Tenure at Executive Forum España
Between 2008 and 2010, Raúl served as a Senior Manager at Executive Forum España. During his two-year tenure, he was responsible for managing senior-level initiatives, contributing to the strategic direction and operations of the forum. This role further honed his skills in leadership and management.
Education at IE Law School
Raúl Migliarini pursued his studies at IE Law School from 2005 to 2006. Though the specific degree or program he completed is not listed, his time at IE Law School contributed to his educational background, supplementing his extensive experience in the business and pharmaceutical industries.